Abiopharma

News list

📋 Garg Pushkal (Officer) plans to sell 5K shares of ALNYLAM PHARMACEUTICALS, INC. (at $331.34 each, total $1.5M) Filed: Feb 27, 2026 | ID: 000253

Full text

News bot Feb. 27, 2026, 9:06 p.m.
📋 Form 144 Filing: Garg Pushkal

Company: ALNYLAM PHARMACEUTICALS, INC.

Filing Date: 2026-02-27

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 4,627
- Price per Share: $331.34
- Total Value: $1,533,106.94
- Planned Sale Date: 2026-02-27
- Broker: UBS Financial Services, Inc.
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36407
- Issuer Contact Phone: (617) 551-8200
- Issuer Address: 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Broker Address: 11 Madison Avenue, 4th Floor, New York, NY, 10010
- Shares Outstanding: 132623144.0
- Number of Securities to be Sold: 2
- Signature: /s/ UBS Financial Services Inc, as attorney-in-fact for Pushkal Garg
- Plan Adoption Dates: 2024-11-20